Inozyme Pharma to Present Recently Announced Preliminary Data from Ongoing Phase 1/2…
<!-- Name:DistributionId Value:8807822 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Preliminary
BridgeBio Pharma to Present Preliminary Findings on its Novel Bioassay Measuring…
<!-- Name:DistributionId Value:8790244 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
PSG’s Achraf Hakimi given preliminary charges on rape allegation
Paris Saint-Germain defender Achraf Hakimi was given preliminary charges of rape. File.
| Photo Credit: AP
Paris Saint-Germain defender Achraf Hakimi was given preliminary charges of rape,…
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial…
LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today…
U.S. judge grants preliminary approval to Juul settlement By Reuters
© Reuters. FILE PHOTO: Juul e-cigarettes are seen on the counter of a vape store in Santa Monica, California, U.S., June 23, 2022. REUTERS/Lucy Nicholson
(Reuters) -Juul Labs Inc won…
Aspira Women’s Health Announces Preliminary Fourth Quarter 2022 Volume, Preliminary…
Preliminary testing volume during the fourth quarter of 2022 was 5,643, an increase of 18 % compared to the fourth quarter of 2021 Preliminary results consistent with previously…
Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures…
LAVAL, Québec, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three…
NGM Bio Presents Preliminary Data from Phase 1 Monotherapy Dose Escalation Trial of…
NGM707 was generally well tolerated to the highest dose evaluated (1800 mg) in the monotherapy escalation; maximum tolerated dose was not reachedLinear pharmacokinetics (PK) was observed at…
Sorrento Releases Positive Topline Results from the Phase I Study Completed in…
Topline safety and pharmacokinetic (PK) data from the Phase I single ascending dose (SAD)/multiple ascending dose (MAD) study of STI-1558 in 58 healthy volunteers in Australia are now…